Penicillin G sodium dosage and administration: Difference between revisions

Jump to navigation Jump to search
Mohamed Moubarak (talk | contribs)
No edit summary
Mohamed Moubarak (talk | contribs)
No edit summary
Line 6: Line 6:
*'''Adult patients'''
*'''Adult patients'''


[[File:PCN G sodium Dosage1.jpg|750]]
[[File:PCN G sodium Dosage1.jpg|750px]]


[[File:PCN G sodium dosage2.jpg|750]]
[[File:PCN G sodium dosage2.jpg|750px]]


*'''Pediatric patients'''
*'''Pediatric patients'''

Revision as of 06:35, 4 January 2014

Penicillin G sodium
PENICILLIN G SODIUM® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Dosage and Administration

  • Adult patients

  • Pediatric patients

This product should not be administered to patients requiring less than one million units per dose. (see PRECAUTIONS - Pediatric Use).

  • Renal Impairment

Penicillin G is relatively nontoxic, and dosage adjustments are generally required only in cases of severe renal impairment.

The recommended dosage regimens are as follows:

Creatinine clearance less than 10 mL/min/1.73 m2; administer a full loading dose (see recommended dosages in the tables above) followed by one-half of the loading dose every 8 to 10 hours.

Uremic patients with a creatinine clearance greater than 10 mL/min/1.73m2; administer a full loading dose (see recommended dosages in the tables above) followed by one-half of the loading dose every 4 to 5 hours.

Additional dosage modifications should be made in patients with hepatic disease and renal impairment.

For most acute infections, treatment should be continued for at least 48 to 72 hours after the patient becomes asymptomatic. Antibiotic therapy for Group A β-hemolytic straptococcal infections should be maintained for at least 10 days to reduce the risk of rheumatic fever.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

  • Preparation of Solution

Solutions of penicillin should be prepared as follows: Loosen powder. Hold vial horizontally and rotate it while slowly directing the stream of diluent against the wall of the vial. Shake vial vigorously after all the diluent has been added. Depending on the route of administration, use Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Dextrose Injections, USP.

Note: Penicillins are rapidly inactivated in the presence of carbohydrate solutions at alkaline pH.